Edition:
United States

Benitec Biopharma Ltd (BNTC.OQ)

BNTC.OQ on NASDAQ Stock Exchange Capital Market

3.18USD
23 Apr 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$3.18
Open
$3.26
Day's High
$3.26
Day's Low
$3.18
Volume
6,703
Avg. Vol
4,417
52-wk High
$4.15
52-wk Low
$1.85

Chart for

About

No overview information found for .
No analyst recommendations are available for .

Overall

No Ratios Available.

Financials

  BNTC.OQ Industry Sector
P/E (TTM): -- 185.04 32.78
EPS (TTM): -- -- --
ROI: -- -0.74 13.21
ROE: -- -2.80 15.01

BRIEF-Benitec Biopharma ‍Says U.S. FDA Granted Orphan Drug Designation To BB-301​

* ‍U.S. FDA HAS GRANTED ORPHAN DRUG DESIGNATION TO BB-301 FOR TREATMENT OF OCULOPHARYNGEAL MUSCULAR DYSTROPHY(OPMD)​ Source text for Eikon: Further company coverage:

Jan 14 2018

BRIEF-Benitec Biopharma Posts Qtrly ‍Loss Of A$2.9 mln

* QTRLY ‍LOSS OF A$2.9 MILLION VERSUS PROFIT OF A$0.8 MILLION​ Source text for Eikon: Further company coverage:

Nov 29 2017

BRIEF-Benitec Biopharma provides update On Opmd Orphan Disease program

* BENITEC BIOPHARMA PROVIDES UPDATE ON OPMD ORPHAN DISEASE PROGRAM

Nov 27 2017

Earnings vs. Estimates